Back to Top Skip to main content Skip to sub-navigation

Brief Report: Medical Encounters for Snakebite Envenomation, Active and Reserve Components, U.S. Armed Forces, 2016–2020

Masters of camouflage, the Sidewinder Rattlesnakes are out and about aboard Marine Corps Logistics Base Barstow, California, May 11. Watch where you put your hands and feet, and observe children and pets at all times, as this is the natural habitat for these venomous snakes and a bite can cause serious medical problems. Notice the sharp arrow-shaped head with pronounced jaws, and the raised eye sockets, as well as the telltale rattles. Keep in mind, however, that rattles can be broken or lost, so you may or may not hear a rattle before they strike to protect themselves. Masters of camouflage, the Sidewinder Rattlesnakes are out and about aboard Marine Corps Logistics Base Barstow, California, May 11. Watch where you put your hands and feet, and observe children and pets at all times, as this is the natural habitat for these venomous snakes and a bite can cause serious medical problems. Notice the sharp arrow-shaped head with pronounced jaws, and the raised eye sockets, as well as the telltale rattles. Keep in mind, however, that rattles can be broken or lost, so you may or may not hear a rattle before they strike to protect themselves.

Recommended Content:

Medical Surveillance Monthly Report

Background

Of the approximately 3,000 known snake species in the world, about 20% (i.e., 600 species) are venomous.1 Snakebite envenomation (SBE) occurs when venom is injected into a human or animal via a snake's fangs, or much less frequently, via spitting venom into a victim's eye or open wound. Not all snakebites result in envenomation; an estimated 25% to 50% of snakebites are "dry bites" in which an insufficient amount of venom is injected to cause clinical symptoms.2,3 Clinical effects of snake envenomation can range from mild local effects (e.g., superficial puncture wounds, pain and swelling) to more severe complications including permanent disability and death.3

SBEs are a significant public health issue especially in the tropical and subtropical areas of Africa, Asia, and Latin America.4 In 2017, the World Health Organization (WHO) identified SBE as a neglected tropical disease. WHO estimates between 1.8-2.7 million SBEs occur annually, resulting in an estimated 81,410 to 137,880 deaths.5 Each year in the U.S., there are an estimated 5,000-10,000 SBEs and fewer than 10 associated deaths.6

Although rare, SBEs are an occupational hazard for military members worldwide. The recent published literature on SBE in military members is sparse. During contingency operations in Iraq and Afghanistan, self-reported incidence of snakebite in U.S. troops was 4.9 snakebites per 10,000 person-months.7 A recent review of snakebites treated between 2015-2017 by the French military health service in overseas locations identified only two soldiers (1 French, 1 Dutch) treated for SBE in Mali, both of whom were treated with antivenom and recovered fully.8 A 2018 summary of snakebites in UK personnel focused on Europe and Africa and reported on an envenomation in a UK service member bitten by a horned viper in Croatia. This summary also highlighted that the majority of SBE cases treated by military medical providers occurred among local civilians.9 The only death attributed to SBE in a U.S. service member that was reported in the lay press occurred in 2015 in Kenya.10

No comprehensive summary of all medically diagnosed SBEs in U.S. service members worldwide has been published. This analysis summarizes the incidence of SBE in active and reserve component service members identified through review of administrative medical data. This analysis also provides a breakdown of SBEs by demographic and military characteristics including the country and combatant command in which the SBEs were treated.

Methods

The surveillance period was from 1 January 2016 through 31 December 2020. The surveillance population included all individuals who served in the active or reserve component of the U.S. Army, Navy, Air Force, or Marine Corps at any time during the surveillance period. The Defense Medical Surveillance System (DMSS) was searched for all inpatient, outpatient and/ or theater medical encounters that contained any of the ICD-10 codes falling under the parent code T63.0 ("Toxic effect of snake venom") in any diagnostic position. Because ICD-9 diagnoses still appear in the theater medical encounter data, service members could also qualify as a case if they had a diagnosis of ICD-9: 989.5 ("Toxic effect of venom") or E905.0 ("Venomous snakes and lizards causing poisoning and toxic reactions"). The patient assessment field was reviewed for these ICD-9 coded records to determine whether the injury was caused by a snake, and only the records for injuries that were caused by snakes were retained. A service member could be counted as an incident case once per year. The location of the SBE was determined by mapping the treating facility for the SBE to a specific country and combatant command.

Results

During the 5-year surveillance period, a total of 345 SBEs were diagnosed in U.S. service members. Approximately 90% of cases were among male service members and about 45% occurred in soldiers. More than three-quarters of SBEs were diagnosed among active component service members (Table). The majority of cases occurred in service members in the 20-29 year old age group. Service members in the repair/engineering and combat-specific occupational groups were the most frequently affected by SBEs and constituted over half of all SBEs during the period (Table).

The annual numbers of SBEs were at their highest in 2017 (n=83); this peak represented a 9.2% increase in SBEs over the prior year. Total SBEs declined by 22.6% in 2018 and a further 9.4% in 2019; 2019 had the lowest number of incident cases of SBE during the surveillance period (n=58). Incident cases increased by 10.3% in 2020 (n=64) which was the same level as 2018 (Figure 1). Overall, 59.4% (n=205) of the cases occurred between the months of June and September (Figure 2).

Most SBE cases (96.2%) were diagnosed in the U.S.; consequently, almost 96% of cases occurred in the U.S. Northern Command (Table). Cases diagnosed in Hawaii are attributed to the U.S. IndoPacific Command. Counts of cases by specific location were 1 in Puerto Rico, 330 in the U.S. (excluding Hawaii), 5 in Guam, 4 in Japan, 2 in Korea, 2 in Hawaii, and 1 with an unknown location.

Editorial Comments

This analysis demonstrates that the vast majority of medically diagnosed SBEs in U.S. service members during 2016-2020 occurred in the U.S. In accordance with the findings of a recent report on the epidemiology of snakebites in the U.S., male service members were disproportionately affected by SBEs.6

This analysis is subject to the same limitations as any analysis of administrative medical data. Only SBEs that were diagnosed by a medical provider and entered into a service member's electronic medical record could be included in this analysis. An SBE could also be missed due to miscoding or because medical care for an SBE was not documented in the medical record.

In the U.S., service member SBEs occur more frequently during warm weather months. Preventive measures for avoiding SBE include precautions such as avoiding snakes in the wild, wearing long pants or boots when working or walking outdoors, and wearing gloves when handling brush or reaching into areas that might house snakes. Anyone bitten by a snake should seek medical attention as soon as possible.11,12

Although this analysis demonstrates that the majority of service members' SBEs occur in the U.S., appropriate precautions should be taken to avoid SBE during deployment outside of the U.S. Planning for deployment should include education in the medically important snake species and the appropriate medical management of snakebites specific to deployment location. In 2020, the Joint Trauma System published a Clinical Practice Guideline for Global Snake Envenomation Management (CPG ID:81) which provides a comprehensive guide to snakebite management by combatant command.12

References

  1. Venemous snakes distribution and species risk categories. World Health Organization. Accessed 08 May 2021. https://apps.who.int/bloodproducts/snakeantivenoms/database/
  2. Pucca MB, Knudsen C, S Oliveira I, et al. Current Knowledge on Snake Dry Bites. Toxins (Basel). 2020;12(11):668.
  3. Joint Trauma System Clinical Practice Guideline: Global Snake Envenomation Management. Accessed 08 May 2021. https://jts.amedd.army.mil/assets/docs/cpgs/Global_Snake_Envenomation_Management_30_Jun_2020_ID81.pdf
  4. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218.
  5. World Health Organization. Snake bite envenomation. 2019. World Health Organization. Accessed April 29, 2020. https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming
  6. Greene SC, Folt J, Wyatt K, Brandehoff NP. Epidemiology of fatal snakebites in the United States 1989-2018. Am J Emerg Med. 2020 Aug 29:S0735-6757(20)30777-30784.
  7. Shiau DT, Sanders JW, Putnam SD, et al. Selfreported incidence of snake, spider, and scorpion encounters among deployed U.S. military in Iraq and Afghanistan. Mil Med. 2007;172(10):1099-1102.
  8. Bomba A, Favaro P, Haus R, et al. Review of Scorpion Stings and Snakebites Treated by the French Military Health Service During Overseas Operations Between 2015 and 2017. Wilderness Environ Med. 2020;31(2):174-180.
  9. Wilkins D, Burns DS, Wilson D, Warrell DA, Lamb LEM. Snakebites in Africa and Europe: a military perspective and update for contemporary operations. J R Army Med Corps. 2018 Sep;164(5):370-379.
  10. Montgomery, Nancy. Soldier died of venomous snake bite, autopsy confirms. Stars and Stripes. March 15, 2015. Accessed May 08, 2021. https://www.stripes.com/news/soldier-died-of-venomous-snake-bite-autopsy-confirms-1.334382
  11. Torpy JM, Schwartz LA, Golub RM. JAMA patient page. Snakebite. JAMA. 2012;307(15):1657.

FIGURE 1. Annual counts of incident cases of snakebite envenomations, by sex, active and reserve component service members, U.S. Armed Forces, 2016–2020

FIGURE 2. Cumulative number of incident snakebite envenomations, by month, active and reserve component service members, U.S Armed Forces, 2016–2020

TABLE. Demographic and military characteristics of incident cases of snakebite envenomation, U.S. Armed Forces, 2016–2020

You also may be interested in...

Surveillance Snapshot: Illness and Injury Burdens, Recruit Trainees, Active Component, U.S. Armed Forces, 2019

Article
5/1/2020
A Marine Corps Staff Sgt inspects a platoon. (U.S. Marine Corps Lance Cpl. Zachary Beatty)

Recommended Content:

Medical Surveillance Monthly Report

Special Report: Early Use of ICD-10-CM Code “U07.1, COVID-19” to Identify 2019 Novel Coronavirus Cases in Military Health System Administrative Data

Article
5/1/2020
The hospital ship USNS Comfort returns to its homeport after treating patients in New York and New Jersey in support of the COVID-19 pandemic. (U.S. Navy photo by Mass Communication Specialist 1st Class Joshua D. Sheppard/Releaseds)

Recommended Content:

Medical Surveillance Monthly Report

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Active Component, U.S. Armed Forces, 2019

Article
5/1/2020
A physician examines and educates a patient. (U.S. Navy photo by Jacob Sippel, Naval Hospital Jacksonville/Released)

Recommended Content:

Medical Surveillance Monthly Report

Special Report: Prevalence of Selected Underlying Health Conditions Among Active Component Army Service Members with Coronavirus Disease 2019, 11 February–6 April 2020

Article
5/1/2020
The hospital ship USNS Comfort returns to its homeport after treating patients in New York and New Jersey in support of the COVID-19 pandemic. (U.S. Navy photo by Mass Communication Specialist 1st Class Joshua D. Sheppard/Releaseds)

Recommended Content:

Medical Surveillance Monthly Report

Ambulatory Visits, Active Component, U.S. Armed Forces, 2019

Article
5/1/2020
A U.S. naval officer listens through his stethoscope to hear his patient’s lungs at Camp Schwab in Okinawa, Japan in 2018. (U.S. Marine Corps photo by Lance Cpl. Cameron Parks)

Recommended Content:

Medical Surveillance Monthly Report

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Members, U.S. Armed Forces, 2019

Article
5/1/2020
A physician examines and educates a patient. (U.S. Navy photo by Jacob Sippel, Naval Hospital Jacksonville/Released)

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Members, U.S. Armed Forces, 2019

Recommended Content:

Medical Surveillance Monthly Report

Hospitalizations, Active Component, U.S. Armed Forces, 2019

Article
5/1/2020
Service members assigned to Expeditionary Resuscitative Surgical System 19 prepare medical supplies aboard Royal Fleet Auxiliary ship Cardigan Bay during exercise Azraq Serpent 18. (U.S. Navy photo by Mass Communication Specialist 2nd Class Kevin J. Steinberg)

Recommended Content:

Medical Surveillance Monthly Report

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Non-service Member Beneficiaries of the Military Health System, 2019

Article
5/1/2020
A Navy doctor examines a young patient. (U.S. Navy photo by Chief Mass Communication Specialist Michael O’Day/Released)

Recommended Content:

Medical Surveillance Monthly Report

Medical Evacuations out of the U.S. Central Command, Active and Reserve Components, U.S. Armed Forces, 2019

Article
5/1/2020
Airmen from the 19th Medical Group litter-carry a simulated patient onto a C-130J during an aeromedical evacuation training mission at Little Rock Air Force Base in 2019. (U.S. Air Force photo)

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Illness and Injury Burdens, Reserve Component, U.S. Armed Forces, 2019

Article
5/1/2020
Soldiers from each of the United States Army’s three components partnered together to conduct a training exercise at Joint Base Lewis-McChord, Washington, in January 2020. (U.S. Army Reserve photo by Capt. Gurney F. Pearsall III)

Recommended Content:

Medical Surveillance Monthly Report

Commentary: The Warrior Heat- and Exertion-Related Event Collaborative and the Fort Benning Heat Center

Article
4/1/2020
A U.S. Navy Basic Underwater Demolition/SEAL student moves through the weaver during an obstacle course session in the first phase of training. (U.S. Navy photo by Mass Communication Specialist 2nd Class Kyle D. Gahlau/Released)

Recommended Content:

Medical Surveillance Monthly Report

Update: Heat Illness, Active Component, U.S. Armed Forces, 2019

Article
4/1/2020
Service members from Joint Task Force-Bravo participate in Chapel Hike 75. In spite of the heat, sun and exhaustion, service members were enthusiastically hiking the road mountain to provide food for the local community. (U.S. Army photo by Martin Chahin)

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2004–2019

Article
4/1/2020
Builder 3rd Class, assigned to Mobile Construction Battalion (NMCB) 1, detachment Guam, drinks water while reconstructing a roof for a home that was damaged during Typhoon Mangkhut. U.S. Navy photo by Mass Communication Specialist 2nd Class Kelsey J. Hockenberger)

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2015–2019

Article
4/1/2020
Midshipmen from the U.S Naval Academy Class of 2016 conduct a log carrying exercise. (U.S. Navy photo by Mass Communication Specialist 2nd Class Todd Frantom)

Update: Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2015–2019

Recommended Content:

Medical Surveillance Monthly Report

Update: Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2011-2019

Article
3/1/2020
Photomicrograph of a Gram-stained specimen demonstrating the presence of Gram-negative, intracellular diplococci, which is a finding indicative of the possible presence of Neisseria gonorrhoeae bacteria. Credit: CDC/Bill Schwartz

Recommended Content:

Medical Surveillance Monthly Report
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 14

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.